Skip to main content
Please join Noticeboard
You are offline
Good Health and Well-being
May 10, 2021

AstraZeneca jab is safe and effective, says WHO

Abishek Good Health and Well-being

AstraZeneca’s Covid-19 vaccine is safe and effective and should be deployed widely, including in countries where the South African variant of the coronavirus may reduce its efficacy, a World Health Organisation panel said on Wednesday. In interim recommendations on the shot, the Strategic Advisory Group of Experts on Immunisation (SAGE) panel said the vaccine should be given in two doses with an interval of 8 to 12 weeks, and should also be used in people aged 65 and older. Even in countries such as South Africa, where questions have been raised about the AstraZeneca vaccine’s efficacy against a newly-emerged variant of the SARS-CoV-2 coronavirus, “there is no reason not to recommend its use”, SAGE’s chair, Alejandro Cravioto, told a briefing.“We have made a recommendation that even if there is a reduction in the possibility of this vaccine having a full impact in its protection capacity, especially against severe disease, there is no reason not to recommend its use even in countries that have circulation of the variant,” he said

Discussion (0)

No comments yet

This notice is currently unavailable

It may have been set to private or is under review

This notice has expired

This notice has been removed

The content is no longer available

AstraZeneca jab is safe and effective, says WHO

Good Health and Well-being

AstraZeneca’s Covid-19 vaccine is safe and effective and should be deployed widely, including in countries where the South African variant of the coronavirus may reduce its efficacy, a World Health Organisation panel said on Wednesday. In interim recommendations on the shot, the Strategic Advisory Group of Experts on Immunisation (SAGE) panel said the vaccine should be given in two doses with an interval of 8 to 12 weeks, and should also be used in people aged 65 and older. Even in countries such as South Africa, where questions have been raised about the AstraZeneca vaccine’s efficacy against a newly-emerged variant of the SARS-CoV-2 coronavirus, “there is no reason not to recommend its use”, SAGE’s chair, Alejandro Cravioto, told a briefing.“We have made a recommendation that even if there is a reduction in the possibility of this vaccine having a full impact in its protection capacity, especially against severe disease, there is no reason not to recommend its use even in countries that have circulation of the variant,” he said

Recent Searches

Recent Noticeboards

No results found

Try a different search term

Something went wrong

No notices yet

No notices match these filters

Couldn't load notices

You're all caught up 🎉

Message

Create 3 Noticeboards to earn this Silver level Community Champion Badge.

View all badges that you can earn

You're only a minute from joining in

Discover Noticeboards

Report Content

Please tell us why you are reporting this content.